menu

Tag: asco abstract 2022

Updates On the ASCO 2022 Annual Meeting

Updates On the ASCO 2022 Annual Meeting

  • havensmith

Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve...

Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE...

  • havensmith

Junshi’s domestic Toripalimab’s significant results in...

Junshi’s domestic Toripalimab’s significant results in recurrent or metasta...

  • havensmith

Is Paxalisib Better Than Temozolomide In The First-Line...

Paxalisib showed positive and promising results in the phase II trial. (Abs...

  • havensmith

With The Emergence of Next-Generation SERDs, Sanofi Mig...

With The Emergence of Next-Generation SERDs, Sanofi Might Hit The Mark

  • havensmith